These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16081775)

  • 1. Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells.
    Griseri T; Beaudoin L; Novak J; Mars LT; Lepault F; Liblau R; Lehuen A
    J Immunol; 2005 Aug; 175(4):2091-101. PubMed ID: 16081775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts.
    Vizler C; Bercovici N; Heurtier A; Pardigon N; Goude K; Bailly K; Combadière C; Liblau RS
    J Immunol; 2000 Dec; 165(11):6314-21. PubMed ID: 11086068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-dependent induction of noninflammatory dendritic cells by anergic invariant NKT cells minimizes autoimmune inflammation.
    Wang J; Cho S; Ueno A; Cheng L; Xu BY; Desrosiers MD; Shi Y; Yang Y
    J Immunol; 2008 Aug; 181(4):2438-45. PubMed ID: 18684934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic dissection of V alpha 14J alpha 18 natural T cell number and function in autoimmune-prone mice.
    Matsuki N; Stanic AK; Embers ME; Van Kaer L; Morel L; Joyce S
    J Immunol; 2003 Jun; 170(11):5429-37. PubMed ID: 12759418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
    Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; Hooijberg E; Kramer D; Reurs AW; van den Eertwegh AJ; von Blomberg BM; Scheper RJ; Bontkes HJ
    J Immunol; 2008 Aug; 181(4):2446-54. PubMed ID: 18684935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
    Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
    J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
    Kanagawa O; Shimizu J; Vaupel BA
    J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
    Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N
    J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes.
    Chen YG; Choisy-Rossi CM; Holl TM; Chapman HD; Besra GS; Porcelli SA; Shaffer DJ; Roopenian D; Wilson SB; Serreze DV
    J Immunol; 2005 Feb; 174(3):1196-204. PubMed ID: 15661873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
    Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
    J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes.
    Beaudoin L; Diana J; Ghazarian L; Simoni Y; Boitard C; Lehuen A
    Eur J Immunol; 2014 May; 44(5):1454-66. PubMed ID: 24481989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
    Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
    J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma affects homing of diabetogenic T cells.
    Savinov AY; Wong FS; Chervonsky AV
    J Immunol; 2001 Dec; 167(11):6637-43. PubMed ID: 11714835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.
    Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P
    J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes.
    Zhang Y; O'Brien B; Trudeau J; Tan R; Santamaria P; Dutz JP
    J Immunol; 2002 Feb; 168(3):1466-72. PubMed ID: 11801690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
    Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
    J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An altered self-peptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetes.
    Hartemann-Heurtier A; Mars LT; Bercovici N; Desbois S; Cambouris C; Piaggio E; Zappulla J; Saoudi A; Liblau RS
    J Immunol; 2004 Jan; 172(2):915-22. PubMed ID: 14707063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
    Ly D; Mi QS; Hussain S; Delovitch TL
    J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.